ArticleKidney international reports2022
Letter Regarding "Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial".
Yuki Aoki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.